MedTrace Logo

Evaluation of Cardiags Trimod for Analysis of Cardiac Activity

NCT05162599 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-01-25

No results posted yet for this study

Summary

The current study concerns Cardiags Trimod, a new non-invasive medical device for cardiac examinations. The evaluation of its effectiveness is done relative to specific standard devices.

Conditions

  • Murmur, Heart
  • Rhythm; Abnormal

Interventions

DEVICE

Diagnostic study, experimental evaluative cross-sectional study

This is a cross-sectional diagnostic study with collection of information from the gold standard (or reference test) and the new device

Sponsors & Collaborators

  • CARDIAGS

    lead INDUSTRY

Principal Investigators

  • Laurent Mr Boisson, Dr · Hopital Fourvière Lyon France

  • Bernard Mr RITZ, Dr · Hopital Fourvière Lyon France

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-08
Primary Completion
2023-06-08
Completion
2023-06-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05162599 on ClinicalTrials.gov